GL1X · GenesisL1 explorer

MolNFT v1 · #28851 · protein

Escherichia COLI purine nucleoside phosphorylase II, the product of the xapa gene

1YQU · Xanthosine phosphorylase: “Escherichia COLI purine nucleoside phosphorylase II, the product of the xapa gene”. X-ray diffraction, 2 ligands (GUN, PO4), 9 pockets (best druggability 0.86). MolNFT v1 #28851 on GenesisL1: 3D structure…

PDB
1YQU
Type
protein
Length
729 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Xanthosine phosphorylase
EC
2.4.2.-
UniProt
P45563
Ligands
GUN, PO4
Pockets
9 · best druggability 0.86

Structure

x-ray diffraction · 1 distinct chain · 32% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, CXanthosine phosphorylase (EC 2.4.2.-)protein24332% helix, 26% strandP45563

Ligands and binding sites

  • GUN · Guanine · ligand · 3 copies · chains A, B, C
  • PO4 · Phosphate ion · ion · 3 copies · chains A, B, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13090.860.9640empty
21910.500.7735PO4, GUN
31290.460.7824PO4, GUN
41360.460.7723PO4, GUN
52210.450.7331empty

Interfaces

3 interfaces between chains.

  • A–C · 820 Ų buried · 8 hydrogen bonds · protein-protein
  • B–C · 813 Ų buried · 8 hydrogen bonds · protein-protein
  • A–B · 810 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 1YQU · Escherichia coli purine nucleoside phosphorylase II, the product of the xapA gene · the same entry in another collection · chain A against A, TM-score 1.00
  • P45563 · AlphaFold monomer V2.0 prediction for purine nucleoside phosphorylase 2 (P45563) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.